For Blood and Money

For Blood and Money tells the story of an upstart biotechnology company in California that developed a one-in-a-million cancer drug using a BTK inhibitor, which showed remarkable efficacy in treating a vicious type of leukemia.

The book delves into the world of biotech start-ups, detailing the roles of scientists, doctors, investors, and patients in the high-stakes game of drug development.

It explores the complexities of bringing new drugs to market, the reasons behind their high costs, and the influence of profit-driven venture capitalists on the future of medicine.